Testing the discriminating concentration of chlorfenapyr (pyrrole) and A. gambiae sensu lato susceptibility in preparation for distribution of Interceptor® G2 insecticide-treated nets.

Interceptor® G2 is a new dual active ingredient ITN treated with alpha-cypermethrin and chlorfenapyr for the control of pyrethroid-resistant malaria vectors. In anticipation of these new nets being more widely distributed, testing was conducted to develop a chlorfenapyr susceptibility bioassay protocol and gather susceptibility information. (MapVEu VBP0000776)